您的购物车当前为空
别名 伊鲁昔替尼, LY-3411067, LY3411067
Ilunocitinib 是一种非选择性和口服活性的Janus 激酶(JAK)抑制剂,用于控制犬类的过敏性皮炎引起的瘙痒和特应性皮炎。


为众多的药物研发团队赋能,
让新药发现更简单!
Ilunocitinib 是一种非选择性和口服活性的Janus 激酶(JAK)抑制剂,用于控制犬类的过敏性皮炎引起的瘙痒和特应性皮炎。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,160 | In Stock | |
| 5 mg | ¥ 2,570 | In Stock | |
| 10 mg | ¥ 3,980 | In Stock | |
| 25 mg | ¥ 6,270 | In Stock | |
| 50 mg | ¥ 8,460 | In Stock | |
| 100 mg | ¥ 11,300 | In Stock | |
| 200 mg | ¥ 15,300 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,820 | In Stock |
Ilunocitinib 相关产品
| 产品描述 | Ilunocitinib is a non-selective and orally active Janus kinase (JAK) inhibitor for the control of pruritus and atopic dermatitis caused by atopic dermatitis in dogs. |
| 体内活性 | 在犬异位性皮炎模型中,Ilunocitinib(0.6–0.8 mg/kg,口服,每日一次,最长 112 天)可显著缓解瘙痒和皮肤病变,从第 28 天起疗效优于对照药物 Oclacitinib,且具有良好的耐受性[1]。 |
| 别名 | 伊鲁昔替尼, LY-3411067, LY3411067 |
| 分子量 | 383.43 |
| 分子式 | C17H17N7O2S |
| CAS No. | 1187594-14-4 |
| Smiles | N#CCC1(N2N=CC(=C2)C=3N=CN=C4NC=CC43)CN(C1)S(=O)(=O)C5CC5 |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 200 mg/mL (521.61 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (13.04 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容